Although bones have the ability to regenerate and repair themselves, they are generally unable to do so when the injury is larger than a small break or chip.
Cellares to produce Cabaletta’s autoimmune CAR-T candidate
Cellares announced a new partnership with Cabaletta Bio to manufacture the biotech’s autoimmune CAR-T cell therapy candidate through mid-stage clinical trials. Using its Cell Shuttle
November 7, 2023